HONG KONG, Oct 13, 2025 – (ACN Newswire)–Kangji Medical Holdings Limited (“Kangji Medical” or the “Company”, Stock Code: 9997. HK) and Knight Bidco Limited (the “Offeror”) today revealed that a circular in relation to the proposed privatisation of Kangji Medical (the “Scheme Document”) has actually been released, setting out the terms of the proposed privatisation of Kangji Medical (the “Proposal”) by method of a plan of plan.
The file is now readily available on the Stock Exchange of Hong Kong’s site. (site link)
The Proposal represents an appealing chance for Scheme Shareholders to understand their financial investment in the Company with certainty in the middle of market volatility, prospective geopolitical threat, market and macro unpredictability.
Suggestion
The Independent Board Committee (“IBC”having actually thought about the Proposal, the Scheme, and the Special Deal, and having actually taken into consideration the suggestions of the Independent Financial Adviser, thinks about that the Proposal, the Scheme, and the Special Deal are reasonable and sensible insofar as the Independent Shareholders are worried.
Appropriately, the IBC advises that the Independent Shareholders vote in favour of different resolutions to render the Scheme reliable.
Additional info on the factors for the IBC’s suggestion, and the Independent Financial Adviser’s report are readily available in the Scheme Document.
Action needed by Scheme Shareholders
All investors are encouraged to examine the Scheme Document. Investors need to describe the Scheme Document for more details concerning the Proposal, the Scheme and the Special Deal, along with the Notices of the Court Meeting and the EGM, together with the types of proxy in relation thereto.
In accordance with the instructions of the Grand Court, the Court Meeting will be held at 10:00 a.m. (Hong Kong time) on 10 November 2025 at United Conference Centre, 10/F, United Centre, 95 Queensway, Admiralty, Hong Kong. The EGM will be held at the very same location and on the exact same date at 10:30 a.m.
Kangji Medical investors need to thoroughly check out the Scheme Document in its totality before deciding with regard to the Scheme.
Background to the Proposal
On 17 July 2025, the Offeror asked for the Board to advance the Proposal to the Shareholders for the privatisation of the Company by method of a plan of plan under area 86 of the Companies Act. Upon conclusion of the Proposal, the Company will end up being a wholly-owned subsidiary of the Offeror and the listing of the Shares will be withdrawn from the Stock Exchange.
Kangji Medical Holdings Limited
Kangji Medical is a medical gadget group established in 2004 with head office at Hangzhou, Zhejiang Province, China. It was noted at the mainboard of the Stock Exchange of Hong Kong in June 2020 (Stock Code: 9997. HK). The Company focus on the style, advancement, manufacture and sale of minimally intrusive surgical treatment instruments and devices (“MISIA”). It pursues the objective of “supplying doctors with premium product or services, and committing to enhance individuals’s health”. The Company uses an extensive item portfolio to supply doctors and health centers one-stop and customized surgical services mostly for 4 significant surgical specializeds, consisting of obstetrics and gynecology, basic surgical treatment, urology, and thoracic surgical treatment. It likewise devoted to establishing a globally acknowledged minimally intrusive surgical treatment instruments and devices platform with international protection.
About Knight Bidco Limited
Each of the Offeror, MidCo and TopCo is a recently integrated business in the Cayman Islands with minimal liability and a financial investment holding business established exclusively for the functions of executing the Proposal. As at the most recent Practicable Date, the Offeror is completely owned by MidCo, which in turn is completely owned by TopCo. As at the most recent Practicable Date, TopCo is held by the Consortium Members, regarding around 25.53% by Fortune Spring ZM, roughly 14.47% by Fortune Spring YG, around 24.38% by TPG Asia VII, roughly 5.01% by Keyhole, around 5.69% by Knight Success, roughly 4.56% by NewQuest V and roughly 20.36% by Al-Rayyan Holding. As at the most recent Practicable Date, conserve as divulged in the area headed “11. Shareholding Structure of the Company” in Part VII– Explanatory Memorandum of the Scheme Document, none of TPG Asia VII, Keyhole, Knight Success, NewQuest V and Al-Rayyan Holding is a Shareholder.
Kangji Medical is managed by Mr. Zhong and his partner Ms. Shentu who together hold 52.98% of the shares in Kangji Medical. Following the privatisation of Kangji Medical, Mr. Zhong and Ms. Shentu will stay the biggest investors in the supreme moms and dad business of the Offeror, holding 40.00% of the shares in TopCo by means of Fortune Spring ZM and Fortune Spring YG. More information are offered in the Scheme Document.
Each of the Founder Entities is a service company included in the British Virgin Islands.
Knight Success is a freshly included business in Singapore with minimal liability and a financial investment holding business. Keyhole is an excused business included in the Cayman Islands with minimal liability and a financial investment holding business. TPG Asia VII is a business included in Singapore with restricted liability. Each of Knight Success and Keyhole is either completely owned or managed by TPG Asia VII, which remains in turn managed by TPG Asia GenPar VII Advisors, Inc. and eventually managed by TPG Inc., an openly traded Delaware corporation (NASDAQ).
TPG is a leading international alternative property management company established in 1992 with more than US$ 269 billion of possessions under management since 30 June 2025. For several years, TPG has actually been buying improvement, development, and development and intends to construct vibrant items and techniques for its financiers while likewise setting up discipline and functional quality throughout its financial investment methods and efficiency of its portfolios.
NewQuest V is a business integrated in Singapore with restricted liability and a financial investment holding business. NewQuest V is completely owned by NewQuest Asia Fund V, L.P., which remains in turn managed by NewQuest Asia Fund V GP Ltd. and eventually managed by TPG Inc., an openly traded Delaware corporation (NASDAQ).
Developed in 2011, NewQuest is among Asia’s leading secondary personal equity platforms with the most skilled secondary group in Asia throughout 5 workplaces. Given that its starting, NewQuest has actually concentrated on dealing with GPs to produce bespoke, customized services to satisfy liquidity and other tactical requirements of personal possession owners and their stakeholders. Beginning with a tactical collaboration created in 2018, NewQuest ended up being entirely owned by TPG in January 2022.
Al-Rayyan Holding is a restricted liability business developed in 2012 under the policies of the Qatar Financial Centre Authority in the State of Qatar, and is a 100%-owned indirect subsidiary of QIA, the sovereign wealth fund of the State of Qatar. QIA was established in 2005 to invest and handle the state reserve funds. QIA is amongst the biggest and most active sovereign wealth funds worldwide. QIA invests throughout a wide variety of possession classes and areas in addition to in collaboration with leading organizations around the globe to develop an international and varied financial investment portfolio with a long-lasting outlook. As at the current Practicable Date, Al-Rayyan Holding and its performance celebrations (aside from those who are, or considered to be, acting in show with Al-Rayyan Holding entirely in connection with the Consortium) are not thinking about any Shares.
All capitalized terms which are utilized in this news release however not otherwise specified herein will have the significances credited them in the Scheme Document dated 13 October 2025. This news release ought to read in combination with the Scheme Document, a copy of which is offered on (site link).
Subject: Press release summary
Sectors: BioTech, Healthcare & & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights booked. A department of Asia Corporate News Network.
